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The COVID-19 pandemic has brought with 
it multiple threats to mental wellbeing — 
the possibility or reality of serious physical 
illness; complex COVID-related bereavement; 
lockdowns that cause isolation and inhibit 
social contact, or that can increase exposure 
to abuse in the family; caring for children 
unable to go to school; and precarious 
employment and redundancy, failing 
businesses, and financial insecurity. The 
pandemic has exacerbated the longstanding 
pressure on resources and underinvestment 
in both statutory mental health and wider 
community services. Against this background 
we outline the current evidence for impact of 
COVID-19 on self-harm and suicide rates, and 
we consider how primary care can contribute 
to suicide prevention during COVID-19 and 
after the acute crisis has passed.
IMPACT OF COVID-19 ON MENTAL HEALTH 
There is international evidence of raised 
prevalence of anxiety disorder, post-traumatic 
stress disorder, and depression symptoms, 
especially during lockdowns implemented to 
contain COVID-19, and particularly in young 
people and those living with children.1,2 Those 
with pre-existing mental and chronic illness 
may be at higher risk.3 These increases in 
prevalence of symptoms of mental illness 
are important in their own right, and may also 
increase suicide risk. 
SELF-HARM, SUICIDE, AND COVID-19 
Self-harm is the strongest risk factor for 
suicide. Although thoughts of self-harm and 
suicide are common accompaniments of 
adversity and poor mental health, evidence 
to date has not indicated increased rates 
of self-harm during the UK’s COVID-19 
epoch.4 Data from electronic health records 
in UK general practice identified substantial 
reductions in recorded incident diagnoses 
of anxiety disorders, depression, and self-
harm episodes during April 2020 compared 
to previous years.5 Although these rates had 
returned to expected levels in England by 
mid-September 2020, we do not yet know 
the impact of the subsequent stringent 
regional restrictions and two successive 
national lockdowns. Marked reductions in 
help seeking are potentially worrying and 
warrant close observation. These records-
based investigations, however, cannot reveal 
whether self-harm incidence has fallen 
commensurately in the community, since the 
COVID-19 pandemic began.
Suicide is complex and rarely due to a 
single cause. Evidence about the impact 
of COVID-19 on suicide rates is emerging. 
There was a reported rise in thoughts about 
suicide among young people in the UK during 
early phases of the pandemic, but such 
thoughts are common in distress and do 
not necessarily predict subsequent suicide.6 
During the spring and summer months of 
2020, suicide rates in the UK and other 
western countries were found not to have 
increased;7 however, increased suicide rates 
were reported in females and young people 
from July to October 2020 in Japan, and, in 
the State of Maryland, US, case counts rose 
among Black residents while falling among 
White residents from March to May 2020.8,9 
For self-harm and suicide, it is possible 
that the incidence may have risen during 
the challenging 2020–21 winter months, and 
risk could rise further in the aftermath of 
COVID-19, especially as the economic impact 
of the crisis takes full effect. Thus, ongoing 
monitoring of these patterns is crucial.  
THE ROLE OF PRIMARY CARE 
Suicide prevention is considered a multisector 
public health responsibility, and within this, 
primary care is a setting where most people 
(up to 85%) who die by suicide have been 
seen in general practice the year before, and 
where high-risk groups such as middle-aged 
males aged 45–49 years can be identified.10,11 
Although suicide is a major public health and 
primary care challenge, it can be uncommon 
for some individual practice teams. GPs do, 
however, consult with many patients who are 
distressed, who have harmed themselves, 
and who express suicidal thoughts and intent. 
Evidence is currently lacking, but it is possible 
that levels of distress, anxiety, thoughts about 
suicide, and self-harm in the community 
will increase through the later stages of the 
COVID-19 pandemic and its aftermath, and 
some GPs have already noticed increases in 
these presentations. 
Assessing risk of suicide by stratifying 
people into risk categories or assigning risk 
scores is not a useful way to determine 
what action to take in primary care because 
of poor positive predictive values (ranging 
from 1.3% to 16.7%).12 Particular challenges 
may arise because of overshadowing 
with physical symptoms (including ‘long 
COVID’) and because it is difficult to predict 
when distress will ameliorate naturally as 
situations improve, or when difficulties will 
persist. Nonetheless certain features, alone 
or in combination, should raise concern 
for heightened suicide risk and these are 
highlighted in Box 1. These should aid 
decision-making and can be readily elicited 
in a primary care consultation.
COVID-19 has rapidly changed the primary 
care context, such as the implementation 
of remote consultations to reduce COVID-
19 contagion, but principles of good care 
remain. Therefore, an important element 
of suicide prevention in primary care 
should be to improve mental health care 
for all patients. The response to identified 
heightened suicide risk in primary care 
should include the following components:13
• supported self-management, including 
a discussion about staying safe during 
difficult times and signposting to self-care 
resources (for example, online and third-
sector support);
• follow-up with active surveillance for 
deterioration; and
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Box 1. Concerning clinical features in primary care
•  Sex: suicide is 3 times commoner in males, especially in middle age (45–49 years)
•  History of mental illness, especially with recent inpatient care
•  Chronic physical illness and disability
•  Social adversity: poor social support; social isolation/unconnectedness; loneliness; recent bereavement; 
or unemployment
•  Perceived burdensomeness
•  Low self-worth
•  Hopelessness
•  History of, or current, self-harm and/or alcohol/substance misuse
•  Active plans for suicide and access to means
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• referral to specialist mental health 
services.
Members of the primary care team other 
than GPs, including practice nurses, clinical 
pharmacists, physiotherapists, dentists, and 
physician associates, have an important 
part to play in identifying and intervening 
for patients with suicidal thoughts and self-
harm, which may facilitate early help seeking 
during the COVID-19 crisis. 
For primary care to become an effective 
part of the multi-agency approach to suicide 
prevention during the pandemic and beyond, 
there has to be effective collaborative working 
with other sectors such as the education 
and social care systems, and uniformity in 
approaches. Facilitators and future priorities 
to enable primary care to lead the way in 
suicide prevention during COVID-19 are 
identified below.   
FACILITATORS
Improved communication between mental 
health services, including liaison psychiatric 
and community services, and primary care 
teams can facilitate enhanced management 
for people who have harmed themselves.13 
Tailored services for primary care teams to 
signpost patients who have suicidal thoughts 
or have harmed themselves are needed to 
facilitate effective care for people in distress.13
Third-sector organisations can play a 
supporting role in providing psychological 
therapy for patients who have harmed 
themselves or expressed suicidal thoughts, 
especially given the lack of bespoke provision 
of care for these patients through the 
Improving Access to Psychological Therapies 
programme.14 
FUTURE DIRECTIONS
The planned integrated community and 
primary care mental health services for self-
harm, as outlined in the NHS Long Term 
Plan (www.longtermplan.nhs.uk), may help 
to facilitate rapid intervention and treatment, 
although continued financial investment is 
needed to sustain such services. It is crucial 
that these services communicate effectively 
with primary care teams, are available for 
GPs to refer to, and include young people. 
During 2021, primary care networks 
have the potential to invest in mental health 
professionals working in general practice. 
This may improve care and therapeutic 
relationships for patients at heightened 
suicide risk. Remote consultations provide 
a challenge for clinicians as rapport may be 
detrimentally affected; an evidence base for 
best practice in remote mental health and 
self-harm assessments has not yet been 
established. There is a pressing need for 
research to develop and test primary care 
delivered interventions to reduce self-harm 
and suicide risk in all patients, in partnership 
with patients and the public, to mitigate 
suicide risk during the COVID-19 pandemic 
and beyond.        
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